
Citation: Stephen Schultz, Dario Siniscalco. Endocannabinoid system involvement in autism spectrum disorder: An overview with potential therapeutic applications[J]. AIMS Molecular Science, 2019, 6(1): 27-37. doi: 10.3934/molsci.2019.1.27
[1] | Kento Okuwa, Hisashi Inaba, Toshikazu Kuniya . Mathematical analysis for an age-structured SIRS epidemic model. Mathematical Biosciences and Engineering, 2019, 16(5): 6071-6102. doi: 10.3934/mbe.2019304 |
[2] | Kento Okuwa, Hisashi Inaba, Toshikazu Kuniya . An age-structured epidemic model with boosting and waning of immune status. Mathematical Biosciences and Engineering, 2021, 18(5): 5707-5736. doi: 10.3934/mbe.2021289 |
[3] | Mostafa Adimy, Abdennasser Chekroun, Claudia Pio Ferreira . Global dynamics of a differential-difference system: a case of Kermack-McKendrick SIR model with age-structured protection phase. Mathematical Biosciences and Engineering, 2020, 17(2): 1329-1354. doi: 10.3934/mbe.2020067 |
[4] | Hui Cao, Dongxue Yan, Ao Li . Dynamic analysis of the recurrent epidemic model. Mathematical Biosciences and Engineering, 2019, 16(5): 5972-5990. doi: 10.3934/mbe.2019299 |
[5] | Zhiping Liu, Zhen Jin, Junyuan Yang, Juan Zhang . The backward bifurcation of an age-structured cholera transmission model with saturation incidence. Mathematical Biosciences and Engineering, 2022, 19(12): 12427-12447. doi: 10.3934/mbe.2022580 |
[6] | Xiaohong Tian, Rui Xu, Ning Bai, Jiazhe Lin . Bifurcation analysis of an age-structured SIRI epidemic model. Mathematical Biosciences and Engineering, 2020, 17(6): 7130-7150. doi: 10.3934/mbe.2020366 |
[7] | Fang Zhang, Wenzhe Cui, Yanfei Dai, Yulin Zhao . Bifurcations of an SIRS epidemic model with a general saturated incidence rate. Mathematical Biosciences and Engineering, 2022, 19(11): 10710-10730. doi: 10.3934/mbe.2022501 |
[8] | Abdennasser Chekroun, Mohammed Nor Frioui, Toshikazu Kuniya, Tarik Mohammed Touaoula . Global stability of an age-structured epidemic model with general Lyapunov functional. Mathematical Biosciences and Engineering, 2019, 16(3): 1525-1553. doi: 10.3934/mbe.2019073 |
[9] | Maria Guadalupe Vazquez-Peña, Cruz Vargas-De-León, Jorge Velázquez-Castro . Global stability for a mosquito-borne disease model with continuous-time age structure in the susceptible and relapsed host classes. Mathematical Biosciences and Engineering, 2024, 21(11): 7582-7600. doi: 10.3934/mbe.2024333 |
[10] | Yicang Zhou, Zhien Ma . Global stability of a class of discrete age-structured SIS models with immigration. Mathematical Biosciences and Engineering, 2009, 6(2): 409-425. doi: 10.3934/mbe.2009.6.409 |
In the field of mathematical epidemiology, the SIR epidemic model is known as one of the most basic epidemic models, in which the host population is divided into three classes called susceptible, infective and removed [1]. In the study of epidemic models, the basic reproduction number $ {\cal R}_0 $ is one of the key concepts, and it is defined by the expected value of secondary cases produced by a typical infective individual in a totally susceptible population [2]. Mathematically, $ {\cal R}_0 $ is defined by the spectral radius of the next generation operator, and the method of numerical computation of $ {\cal R}_0 $ has been studied for structured epidemic models [3]. In a simple SIR epidemic model given by a system of ordinary differential equations, $ {\cal R}_0 $ completely determines the model dynamics in the sense of global stability of each equilibrium: If $ {\cal R}_0 \leq 1 $, then the disease-free equilibrium is globally asymptotically stable, whereas if $ {\cal R}_0 > 1 $, then the endemic equilibrium is globally asymptotically stable [4, Section 5.5.2]. On the other hand, in some more complicated epidemic models, a stable endemic equilibrium can exist even if $ {\cal R}_0 < 1 $ due to a backward bifurcation [5]. Also, an endemic equilibrium can be destabilized, and a stable periodic solution can arise for $ {\cal R}_0 > 1 $ due to a Hopf bifurcation [6]. Periodic solutions in epidemic models have attracted much attention because they can describe non-seasonal oscillations of epidemics. Some of the known causes of the periodicity in epidemic models are periodic coefficients, time delay, nonlinear incidence and age structure [7,8,9,10]. In this study, we consider the periodicity in an age-structured SIR epidemic model. Age-structured epidemic models have been widely applied for epidemiological considerations in the era of COVID-19 [11].
In the field of mathematical epidemiology, the time elapsed since the infection is called the infection age, whereas the time elapsed since the birth is called the chronological age. For an infection age-structured SIR epidemic model, a complete threshold property of $ {\cal R}_0 $ in the sense of the global stability of each equilibrium was shown by constructing a suitable Lyapunov function [12]. In contrast, for a chronological age-structured SIR epidemic model, the complete threshold property of $ {\cal R}_0 $ does not hold in general. More precisely, although the global stability of the disease-free equilibrium for $ {\cal R}_0 < 1 $ was proved in [13], some additional conditions were needed to guarantee the local or global asymptotic stability of the endemic equilibrium for $ {\cal R}_0 > 1 $ [13,14], and the possibility of the instability of the endemic equilibrium for $ {\cal R}_0 > 1 $ was studied in [15,16,17,18].
In [15], Thieme showed that the unique endemic equilibrium can be unstable for $ {\cal R}_0 > 1 $ in a chronological age-structured SIR epidemic model with age-dependent infectivity. However, the existence of periodic solutions and the occurrence of Hopf bifurcation have not yet been proved for this model. The purpose of this study is to tackle this problem when the transmission rate has a specific form. More precisely, we assume that the transmission rate is a shifted exponential function (see (A5) in the next section) and perform a Hopf bifurcation analysis regarding the infimum of the support of the function as a bifurcation parameter. Epidemiologically, such a shifted exponential function represents the case where infected people do not have infectivity until a certain critical age, and the infectivity decreases in an exponential sense after the critical age. This function enables us to consider a special case studied in [15], where the product of the transmission rate and the stable age distribution is highly concentrated in a particular age class. In this paper, we obtain concrete sufficient conditions for a Hopf bifurcation.
This paper is organized as follows: In Section 2, we introduce the model in this study. In Section 3, we give some preliminaries for the analysis, including the existence and uniqueness of the endemic equilibrium for $ {\cal R}_0 > 1 $. In Section 4, we perform a Hopf bifurcation analysis for a special case where the force of infection in the steady state is equal to the removal rate. We show that there always exists a critical value such that a Hopf bifurcation occurs when the bifurcation parameter reaches it. In Section 5, we perform a more general analysis for the case where the force of infection in the steady state is not equal to the removal rate. We obtain a similar Hopf bifurcation result as in Section 4 when the distance between the force of infection and the removal rate is sufficiently small. Moreover, we numerically confirm a special case where the stability switch of the endemic equilibrium occurs more than once. Finally, Section 6 is devoted to a discussion.
Let $ S(t, a) $, $ I(t, a) $ and $ R(t, a) $ be the susceptible, infective and removed populations of age $ a $ at time $ t $, respectively. In this paper, we consider the following SIR epidemic model with chronological age structure:
$ {(∂∂t+∂∂a)S(t,a)=−Λ(t)S(t,a)−μ(a)S(t,a),t>0, a>0,(∂∂t+∂∂a)I(t,a)=Λ(t)S(t,a)−[μ(a)+γ]I(t,a),t>0, a>0,(∂∂t+∂∂a)R(t,a)=γI(t,a)−μ(a)R(t,a),t>0, a>0,S(t,0)=∫∞0b(a)P(t,a)da,I(t,0)=0,R(t,0)=0,t>0, $
|
(2.1) |
where $ \mu(a) $ is the mortality rate, $ \gamma $ is the removal rate, $ b(a) $ is the birth rate, $ P(t, a) : = S(t, a)+I(t, a)+R(t, a) $ is the population age density, and
$ \Lambda(t) : = \frac{1}{\int_0^\infty P(t, a) da } \int_0^\infty \beta (a) I(t, a) da $ |
is the force of infection with the transmission rate $ \beta(a) $. We assume $ \gamma > 0 $, and the following
(A1) $ \mu \in L_{+, \text{loc}}^1(0, \infty) $, and $ \int_0^\infty \mu(a)da = \infty $.
(A2) $ \int_0^\infty b(a) \ell(a) da = 1 $, where $ \ell(a) : = e^{-\int_0^a \mu(\sigma)d\sigma} $ is the survival probability.
(A3) The population has attained the stable age distribution, that is, $ P(t, a) = P^*(a) : = N\ell(a)/L $ for all $ t > 0 $ and $ a > 0 $, where $ N > 0 $ is the stationary population size, and $ L : = \int_0^\infty \ell(a) da $ is the life expectancy.
Let
$ \tilde{S}(t, a) : = \frac{S(t, a)}{P^*(a)}, \quad \tilde{I}(t, a) : = \frac{I(t, a)}{P^*(a)}. $ |
For notational simplicity, dropping the tildes on $ \tilde{S} $ and $ \tilde{I} $, we obtain the following normalized SI system:
$ {(∂∂t+∂∂a)S(t,a)=−Λ(t)S(t,a),t>0, a>0,(∂∂t+∂∂a)I(t,a)=Λ(t)S(t,a)−γI(t,a),t>0, a>0,S(t,0)=1,I(t,0)=0,t>0, $
|
(2.2) |
where
$ \Lambda(t) = \frac{1}{N} \int_0^\infty \beta(a) P^*(a) I(t, a) da. $ |
Note that these $ S $ and $ I $ are the normalized age-densities satisfying $ 0\leq S, I \leq 1 $, and we can omit the equation of $ R $ as it does not affect the dynamics of system (2.2).
In [15], Thieme investigated the stability of the endemic equilibrium of system (2.2) when it uniquely exists. He analytically showed that it can be destabilized if $ \beta(a)P^*(a) $ is highly concentrated in a particular age class. However, the problem of the existence of periodic solutions when the endemic equilibrium is unstable was unsettled. In this paper, we deal with this problem by applying the method of local Hopf bifurcation theory. In [15], it was assumed that there exist constants $ c_1, c_2 > 0 $ such that $ \beta(a) \ell(a) \leq c_1 e^{-c_2 a} $ for all $ a > 0 $. In this paper, we make the following additional assumptions:
(A4) $ \mu(a) = \mu > 0 $ for all $ a > 0 $.
(A5) There exist $ \beta_0 > 0 $ and $ \tau, k \geq 0 $ such that
$ \beta(a) = \left\{ 0,a<τ,β0e−ka,a≥τ. \right. $
|
In other words, the transmission rate $ \beta(a) $ is a shifted exponential function. One can then see that $ \beta(a) \ell(a) \leq c_1 e^{-c_2 a} $ for all $ a > 0 $ holds for $ c_1 = \beta_0 $ and $ c_2 = \mu+k $. If both $ \beta_0 $ and $ k $ are large, we can say that $ \beta(a)P^*(a) $ is highly concentrated in a particular age $ \tau $ as in the case studied in [15]. Here, we remark that we can consider a different situation where $ \beta(a)P^*(a) $ is exponentially distributed for $ a \geq \tau $. Regarding $ \tau $ as a bifurcation parameter, we investigate the existence of a critical value $ \tau_c > 0 $ such that a Hopf bifurcation occurs, and a periodic solution bifurcates from the endemic equilibrium when $ \tau = \tau_c $.
Let $ X : = L^1(0, a_\dagger) $ and $ X_+ : = L^1_+(0, a_\dagger) $. It is easy to see that system (2.2) always has the disease-free equilibrium $ E^0 = (1, 0) \in X_+ \times X_+ $. Let $ E^* = (S^*, I^*) $ denote an endemic equilibrium of system (2.2). It then holds
$ {dS∗(a)da=−Λ∗S∗(a),a>0,dI∗(a)da=Λ∗S∗(a)−γI∗(a),a>0,S∗(0)=1,I∗(0)=0, $
|
(3.1) |
where the endemic force of infection obeys
$ Λ∗=1N∫∞0β(a)P∗(a)I∗(a)da. $
|
(3.2) |
Solving (3.1), we obtain
$ S∗(a)=e−Λ∗a,I∗(a)=∫a0e−γ(a−σ)Λ∗S∗(σ)dσ=Λ∗e−γa∫a0e(γ−Λ∗)σdσ. $
|
(3.3) |
Substituting the equation of $ I^* $ into the right-hand side of (3.2) and dividing both sides by $ \Lambda^* $, we obtain
$ 1=1N∫∞0β(a)P∗(a)e−γa∫a0e(γ−Λ∗)σdσda. $
|
(3.4) |
Since the right-hand side of (3.4) is monotone decreasing for $ \Lambda^* $, we see that a unique $ \Lambda^* > 0 $ satisfying (3.4) exists if and only if $ {\cal R}_0 > 1 $, where
$ {\cal R}_0 = \frac{1}{N} \int_0^\infty \beta(a) P^*(a) e^{-\gamma a}\int_0^a e^{\gamma \sigma} d\sigma da = \frac{1}{\gamma N} \int_0^\infty \beta(a) P^*(a) (1-e^{-\gamma a} )da $ |
is the basic reproduction number [2] for system (2.2). More precisely, we obtain the following proposition.
Proposition 3.1. If $ {\cal R}_0 > 1 $, then system (2.2) has a unique endemic equilibrium $ E^* = (S^*, I^*) \in X_+ \times (X_+ \setminus \{ 0 \}) $.
Proof. As explained above, if $ {\cal R}_0 > 1 $, then there exists a unique $ \Lambda^* > 0 $ such that (3.4) is satisfied. We then obtain $ S^*(a) $ and $ I^*(a) $ from (3.3). This completes the proof.
In what follows, we assume $ {\cal R}_0 > 1 $ and investigate the local stability of the endemic equilibrium $ E^* $. Let
$ U(t, a) : = S(t, a) - S^*(a), \quad V(t, a) : = I(t, a) - I^*(a), $ |
be the perturbation from $ E^* $. We then have the following linearized system.
$ {(∂∂t+∂∂a)U(t,a)=−Λ∗U(t,a)−S∗(a)N∫∞0β(a)P∗(a)V(t,a)da,t>0, a>0,(∂∂t+∂∂a)V(t,a)=Λ∗U(t,a)+S∗(a)N∫∞0β(a)P∗(a)V(t,a)da−γV(t,a),t>0, a>0,U(t,0)=0,V(t,0)=0,t>0. $
|
(3.5) |
Substituting $ U(t, a) = e^{\lambda t}u(a) $ and $ V(t, a) = e^{\lambda t}v(a) \; (\lambda \in \mathbb{C}) $ into (3.5) and dividing each equation by $ e^{\lambda t} $, we have
$ {(λ+dda)u(a)=−Λ∗u(a)−wS∗(a),a>0,(λ+dda)v(a)=Λ∗u(a)+wS∗(a)−γv(a),a>0,u(0)=0,v(0)=0,w=1N∫∞0β(a)P∗(a)v(a)da. $
|
(3.6) |
We first show that $ \lambda = 0 $ is not an eigenvalue.
Lemma 3.1. If $ \lambda = 0 $, then there exists no $ (u, v) \neq (0, 0) $ satisfying (3.6).
Proof. For $ \lambda = 0 $, recalling that $ S^*(a) = e^{-\Lambda^* a} $, we obtain
$ u(a)=∫a0e−Λ∗(a−σ)[−wS∗(σ)]dσ=−we−Λ∗aa,v(a)=∫a0e−γ(a−σ)[Λ∗u(σ)+wS∗(σ)]dσ=we−γa∫a0e(γ−Λ∗)σ(1−Λ∗σ)dσ. $
|
Substituting the equation of $ v(a) $ into $ w = N^{-1} \int_0^\infty \beta(a)P^*(a)v(a) da $ and dividing both sides by $ w $, we have
$ 1 = \frac{1}{N} \int_0^\infty \beta(a)P^*(a) e^{-\gamma a} \int_0^a e^{(\gamma - \Lambda^*) \sigma} (1 -\Lambda^* \sigma) d\sigma da. $ |
However, by (3.4), we have
$ \frac{1}{N} \int_0^\infty \beta(a)P^*(a) e^{-\gamma a} \int_0^a e^{(\gamma - \Lambda^*) \sigma} (-\Lambda^* \sigma ) d\sigma da = 0, $ |
which is a contradiction. This completes the proof.
By Lemma 3.1, we can focus on $ \lambda \neq 0 $. Recalling that $ S^*(a) = e^{-\Lambda^* a} $, we obtain
$ u(a)=−w∫a0e−(λ+Λ∗)(a−σ)S∗(σ)dσ=−we−Λ∗a1−e−λaλ,v(a)=∫a0e−(λ+γ)(a−σ)[Λ∗u(σ)+wS∗(σ)]dσ=we−(λ+γ)a∫a0e(λ+γ−Λ∗)σ(1−Λ∗1−e−λσλ)dσ=we−(λ+γ)aλ∫a0[(λ−Λ∗)e(λ+γ−Λ∗)σ+Λ∗e(γ−Λ∗)σ]dσ. $
|
Substituting the equation of $ v(a) $ into $ w = \int_0^\infty \beta(a)P^*(a) v(a) da $ and dividing both sides by $ w $, we have
$ 1 = \frac{1}{N} \int_0^\infty \beta(a)P^*(a) \frac{e^{-(\lambda+\gamma) a}}{\lambda} \int_0^a \left[ (\lambda - \Lambda^*) e^{(\lambda+\gamma-\Lambda^*)\sigma} + \Lambda^* e^{(\gamma-\Lambda^*)\sigma} \right] d\sigma da. $ |
Under assumptions (A4) and (A5), this equation can be rewritten as
$ 1=β1λ∫∞τe−(λ+p)a∫a0[(λ−Λ∗)e(λ+γ−Λ∗)σ+Λ∗e(γ−Λ∗)σ]dσda, $
|
(3.7) |
where $ \beta_1 : = \beta_0/L $ and $ p: = k+\mu+\gamma $. Eq (3.7) is the starting point of our Hopf bifurcation analysis.
We now consider a special case where $ \Lambda^* = \gamma $. In this case, Eq (3.7) can be rewritten as
$ 1=β1λ∫∞τe−(λ+p)a∫a0[(λ−γ)eλσ+γ]dσda. $
|
(4.1) |
Since we are interested in a Hopf bifurcation at which $ \mathrm{Re} \lambda = 0 $, we restrict our attention to $ \lambda $ such that $ \mathrm{Re} \lambda > - p $. We can then rewrite (4.1) as
$ 1=β1λ∫∞τe−(λ+p)a[λ−γλ(eλa−1)+γa]da=β1λ2[(λ−γ)(e−pτp−e−(λ+p)τλ+p)+γλe−(λ+p)τλ+p(τ+1λ+p)]. $
|
(4.2) |
On the other hand, from Eq (3.4), we have
$ 1 = \beta_1 \int_\tau^\infty a e^{-p a} da = \beta_1 \left( \frac{\tau}{p} + \frac{1}{p^2} \right) e^{-p\tau}, $ |
and thus,
$ β1=p2epτpτ+1. $
|
(4.3) |
Substituting (4.3) into (4.2), we obtain
$ 1=p2(pτ+1)λ2[(λ−γ)(1p−e−λτλ+p)+γλe−λτλ+p(τ+1λ+p)]=1(pτ+1)λ2(λ+p)2{p(λ−γ)(λ+p)2+p2[−(λ−γ)(λ+p)+γτλ(λ+p)+γλ]e−λτ}, $
|
which is equivalent to
$ (p\tau+1) \lambda^2 (\lambda+p)^2 = p(\lambda-\gamma) (\lambda+p)^2 + p^2 \left[ -(\lambda-\gamma) (\lambda + p) +\gamma \tau \lambda (\lambda + p) + \gamma \lambda \right] e^{-\lambda \tau}. $ |
Hence, we obtain the following characteristic equation:
$ a4λ4+a3λ3+a2λ2+a1λ+a0+(b2λ2+b1λ+b0)e−λτ=0, $
|
(4.4) |
where
$ a4=pτ+1,a3=2p2τ+p,a2=p3τ−p2+γp,a1=−p3+2γp2,a0=γp3,b2=−γp2τ+p2,b1=−γp3τ+p3−2γp2,b0=−γp3. $
|
Note that although $ \lambda = 0 $ satisfies (4.4), we can disregard it by virtue of Lemma 3.1. We now prove the following lemma.
Lemma 4.1. If $ \tau = 0 $, then all nonzero roots $ \lambda $ of the characteristic Eq (4.4) have negative real parts.
Proof. If $ \tau = 0 $, Eq (4.4) can be rewritten as $ \lambda^4 + p \lambda^3 + \gamma p \lambda^2 = 0 $. As $ \lambda \neq 0 $, dividing both sides by $ \lambda^2 $, we have $ \lambda^2+p\lambda + \gamma p = 0 $. We then easily see that all $ \lambda $ have negative real parts because $ p $ and $ \gamma p $ are strictly positive. This completes the proof.
Lemmas 3.1 and 4.1 imply that the endemic equilibrium $ E^* $, which uniquely exists under $ {\cal R}_0 > 1 $, is locally asymptotically stable if $ \tau = 0 $. By the continuity, $ E^* $ is locally asymptotically stable for small $ \tau > 0 $. In what follows, we investigate the existence of a $ \tau_c > 0 $ such that $ E^* $ is locally asymptotically stable for $ \tau \in [0, \tau_c) $ and destabilized at $ \tau = \tau_c $.
We now seek a pair of simple pure imaginary roots $ \lambda = \pm i \omega \ (\omega > 0) $ of the characteristic Eq (4.4). Since all coefficients in (4.4) are real, if $ \lambda = i \omega $ satisfies (4.4), then $ \lambda = -i \omega $ also satisfies (4.4). Therefore, we focus on $ \lambda = i \omega $. Substituting $ \lambda = i \omega $ into (4.4), we have
$ a_4 \omega^4 - i a_3 \omega^3 - a_2 \omega^2 + i a_1 \omega + a_0 + \left( -b_2 \omega^2 + i b_1 \omega + b_0 \right) e^{-i\omega \tau} = 0. $ |
As $ e^{-i\omega \tau} = \cos \omega \tau - i \sin \omega \tau $, we obtain the following two equations for real and imaginary parts, respectively:
$ {a4ω4−a2ω2+a0=(b2ω2−b0)cosωτ−b1ωsinωτ,a3ω3−a1ω=b1ωcosωτ+(b2ω2−b0)sinωτ. $
|
(4.5) |
Taking squares of both sides in the two equations of (4.5) and adding them, we obtain
$ (a_4 \omega^4 - a_2 \omega^2 + a_0)^2 + (a_3\omega^3 - a_1\omega)^2 = (b_2\omega^2 - b_0)^2 + b_1^2 \omega^2. $ |
Rearranging this equation, we obtain
$ ω2[c3(ω2)3+c2(ω2)2+c1ω2+c0]=0 $
|
(4.6) |
(note that $ a_0^2-b_0^2 = 0 $), where
$ c_3 = a_4^2, \quad c_2 = -2 a_2 a_4 + a_3^2, \quad c_1 = 2a_0a_4 + a_2^2 - 2a_1a_3 - b_2^2, \quad c_0 = -2a_0 a_2 + a_1^2 + 2b_0 b_2-b_1^2. $ |
As we can rule out $ \omega = 0 $ by Lemma 3.1, dividing both sides of (4.6) by $ \omega^2 $, we obtain
$ c3(ω2)3+c2(ω2)2+c1ω2+c0=0. $
|
(4.7) |
On the existence of a positive $ \omega > 0 $ satisfying (4.7), we prove the following lemma:
Lemma 4.2. The Eq (4.7) has a unique nonzero positive root $ \omega > 0 $.
Proof. Let $ h(x) = c_3x^3+c_2x^2+c_1x+c_0 $. It suffices to show that $ h(x) = 0 $ has a unique positive root $ x^* > 0 $, for which $ \omega = \sqrt{x^*} > 0 $ is the desired root of (4.7). It is obvious that $ c_3 = (p\tau + 1)^2 > 0 $. Moreover, we have, using $ p = k+\mu+\gamma > \gamma $,
$ c2=−2(p3τ−p2+γp)(pτ+1)+(2p2τ+p)2=2p4τ2+4p3τ+3p2−2γp(pτ+1)>2p4τ2+4p3τ+3p2−2p2(pτ+1)=2p4τ2+2p3τ+p2>0, $
|
and, using $ b_0 = -a_0 $ and $ b_1 = -\gamma p^3 \tau - a_1 $,
$ c0=−2a0(a2+b2)+a21−(γp3τ+a1)2=−2γp3(p3τ+γp−γp2τ)−γ2p6τ2−2γp3τa1=−2γp3(p3τ+γp−γp2τ)−γ2p6τ2−2γp3τ(−p3+2γp2)=−2γ2p4−2γ2p5τ−γ2p6τ2<0. $
|
$ c_0 < 0 $ and $ c_2, c_3 > 0 $ imply that $ h(x) = 0 $ has a unique positive root $ x^* > 0 $. This completes the proof.
The following corollary will be used in the proof of the transversality:
Corollary 4.1. Let $ h(x) $ and $ x^* $ be as defined in the proof of Lemma 4.2. Then, $ h'(x^*) > 0 $.
Proof. The assertion immediately follows from $ c_0 < 0 $ and $ c_2, c_3 > 0 $.
Note that since $ a_2, a_3, a_4, b_1 $ and $ b_2 $ in (4.4) depend on $ \tau $, the root $ \omega $ also depends on $ \tau $: $ \omega = \omega(\tau) $. Since (4.7) is a necessary condition for $ \lambda = i\omega $ to be a root of (4.4), we have to find a $ \tau_c > 0 $ such that $ \omega(\tau_c) $ satisfies not only (4.7) but also (4.5). By (4.5), we have
$ {cosωτ=(a4ω4−a2ω2+a0)(b2ω2−b0)+(a3ω3−a1ω)b1ω(b2ω2−b0)2+b21ω2=:φ,sinωτ=−(a4ω4−a2ω2+a0)b1ω+(a3ω3−a1ω)(b2ω2−b0)(b2ω2−b0)2+b21ω2=:ψ. $
|
(4.8) |
We define $ \theta \in (0, 2\pi] $ by
$ \theta : = \left\{ arccosφ,ψ>0,2π−arccosφ,ψ≤0. \right. $
|
It then follows from (4.8) that $ \omega \tau = \theta $, and thus,
$ \tau = \frac{\theta}{\omega}. $ |
Note that $ \varphi $, $ \psi $ and $ \theta $ also depend on $ \tau $. Let $ f(\tau) : = \theta(\tau)/\omega(\tau) $. Then, the desired $ \tau_c $ is a positive fixed point of $ f $: $ \tau_c = f(\tau_c) $. Before proving the existence of such $ \tau_c $, we give the following lemma:
Lemma 4.3. For coefficients $ c_0, c_1, c_2 $ and $ c_3 $, it holds that
$ \lim\limits_{\tau \to \infty} \frac{1}{(p\tau)^2} \left( c0c1c2c3 \right) = \left( −γ2p4p2(p2−γ2)2p21 \right). $
|
Proof. The convergence of $ c_i/(p\tau)^2 \ (i = 0, 2, 3) $ can be easily checked by using the expressions of $ c_0, c_2 $ and $ c_3 $ given in the proof of Lemma 4.2. For $ c_1 $, we have
$ c1=2γp3(pτ+1)+(p3τ−p2+γp)2−2(−p3+2γp2)(2p2τ+p)−(−γp2τ+p2)2=2γp4τ+2γp3+p6τ2+p4+γ2p2−2p5τ+2γp4τ−2γp3+4p5τ+2p4−8γp4τ−4γp3−γ2p4τ2+2γp4τ−p4=−2γp4τ−4γp3+p6τ2+γ2p2+2p5τ+2p4−γ2p4τ2=(p2−γ2)p4τ2+2(p−γ)p4τ−4γp3+γ2p2+2p4=p2[(p2−γ2)p2τ2+2(p−γ)p2τ−4γp+γ2+2p2], $
|
and hence, $ \lim_{\tau \to \infty} c_1/(p\tau)^2 = p^2(p^2-\gamma^2) $. This completes the proof.
We now prove the following proposition:
Proposition 4.1. There exists a $ \tau_c > 0 $ such that $ \lambda = \pm i \omega(\tau_c) $ is a pair of simple pure imaginary roots of the characteristic Eq (4.4).
Proof. By Lemma 4.2 and its proof, one can see that $ \omega(\tau) $ is continuous and finite for all $ \tau \geq 0 $. Thus, $ \theta(\tau) $ and $ f(\tau) $ are also continuous and finite for all $ \tau \geq 0 $. Moreover, it follows that $ f(0) = \theta(0)/\omega(0) > 0 $. Hence, by the continuity, if $ \lim_{\tau \to \infty}f(\tau) < \infty $, then we can conclude that there exists a $ \tau_c > 0 $ such that $ \tau_c = f(\tau_c) $.
Let $ \{ \tau_n \}_{n = 1}^\infty $ be an increasing sequence in $ (0, \infty) $, and let $ \omega_n : = \omega(\tau_n) $. By dividing both sides of (4.7) by $ (p\tau_n)^2 $, we have
$ \frac{c_3}{(p\tau_n)^2} (\omega^2_n)^3 + \frac{c_2}{(p \tau_n)^2} (\omega^2_n)^2 + \frac{c_1}{(p\tau_n)^2} \omega^2_n + \frac{c_0}{(p\tau_n)^2} = 0. $ |
By Lemma 4.3, we see that $ \{ \omega_n \}_{n = 1}^\infty $ converges to $ \omega_\infty $, which is the unique positive root of the following equation:
$ (\omega_\infty^2)^3 + 2p^2 (\omega_\infty^2)^2 +p^2 (p^2-\gamma^2) \omega_\infty^2 - \gamma^2 p^4 = 0. $ |
Thus, we have $ \lim_{\tau \to \infty}f(\tau) \leq 2\pi/\omega_\infty < \infty $. This completes the proof.
Proposition 4.1 guarantees the existence of a pair of pure imaginary roots at $ \tau = \tau_c > 0 $.
We next investigate the transversality condition at $ \tau = \tau_c $, that is,
$ dReλdτ|λ=iωc>0, $
|
(4.9) |
where $ \omega_c : = \omega(\tau_c) $. Following a general result given by [19], we define $ g(\tau) : = \tau - f(\tau) $. Now, we have the following proposition.
Proposition 4.2. If $ g'(\tau_c) > 0 $, then (4.9) holds.
Proof. Let $ y (\omega) $ be the left-hand side of (4.6):
$ y (\omega) : = \omega^2 \left[ c_3 (\omega^2)^3 + c_2 (\omega^2)^2 + c_1 \omega^2 + c_0 \right] = \omega^2 h(\omega^2). $ |
Following a calculation in [19, Proof of Theorem 2.2] for a general characteristic equation, we can obtain a similar result as in [19, Theorem 2.2]:
$ \mathrm{sign} \left\{ \left. \frac{d \mathrm{Re} \lambda}{d\tau} \right|_{\lambda = i\omega_c} \right\} = \mathrm{sign} \left\{ \frac{\partial y (\omega_c)}{\partial \omega} \right\} \ \mathrm{sign} \left\{ g'(\tau_c) \right\}. $ |
Note that from Lemma 4.2 and Corollary 4.1, it follows that $ h(\omega_c^2) = 0 $ and $ h'(\omega_c^2) > 0 $. We then have that
$ \frac{\partial y (\omega_c)}{\partial \omega} = 2\omega_c h(\omega_c^2) + \omega_c^2 h'(\omega_c^2) 2\omega_c = 2\omega_c^3 h'(\omega_c^2) > 0. $ |
Hence, we have
$ \mathrm{sign} \left\{ \left. \frac{d \mathrm{Re} \lambda}{d\tau} \right|_{\lambda = i\omega_c} \right\} = \mathrm{sign} \left\{ g'(\tau_c) \right\}. $ |
This completes the proof.
As shown in the proof of Proposition 4.1, we have $ f(0) > 0 $ and $ \lim_{\tau \to \infty}f(\tau) < \infty $. This implies that there exists at least one $ \tau_c > 0 $ such that $ g(\tau_c) = \tau_c-f(\tau_c) = 0 $ and $ g'(\tau_c) > 0 $. That is, a Hopf bifurcation is always possible in model (2.2) with $ {\cal R}_0 > 1 $ and $ \Lambda^* = \gamma $. More precisely, we obtain the following main result:
Proposition 4.3. Suppose that $ \beta_1 $ depends on $ \tau $ as for (4.3). Then, $ {\cal R}_0 > 1 $ and $ \Lambda^* = \gamma $ hold for all $ \tau \geq 0 $, and there exists a $ \tau_c > 0 $ such that a pair of simple pure imaginary roots $ \pm i \omega(\tau_c) $ ( = $ \pm i \omega_c $) satisfies the characteristic Eq (4.4) and crosses the imaginary axis from left to right as $ \tau $ increases over $ \tau_c $.
Under the condition in Proposition 4.3, there always exists a critical value $ \tau_c > 0 $ such that a Hopf bifurcation occurs, and a periodic solution arises when the infimum $ \tau $ of the support of function $ \beta(a) $ reaches $ \tau = \tau_c $. In the next subsection, we numerically confirm this result.
For simplicity, we fix $ \mu = \gamma = k = 1 $. Note that these parameters are technically chosen in order to confirm the validity of Proposition 4.3, and thus, there is no biological reason for this choice. In this case, $ p = 3 $, and we can numerically calculate functions $ \omega(\tau) $, $ \theta(\tau) $, $ f(\tau) $ and $ g(\tau) $, and $ \tau_c \approx 3.84 $ as shown in Figure 2. Note that $ L = 1/\mu = 1 $, and the force of infection is
$ \Lambda(t) = \frac{1}{N} \int_0^\infty \beta(a)P^*(a)I(t, a)da = \frac{\beta_0}{L} \int_\tau^\infty e^{-(k+\mu)a} I(t, a)da = \beta_0 \int_\tau^\infty e^{-(k+\mu)a} I(t, a)da. $ |
It then follows from (4.3) that $ \beta_0 = \beta_1 = p^2 e^{p\tau}/(p\tau + 1) $. For the normalized system (2.2), we choose the initial condition as $ S(0, a) = 0.99 $ and $ I(0, a) = 0.01 $ for all $ a > 0 $.
For $ \tau = 3.7 < \tau_c $, we see in Figure 3 that the numerical solutions of $ I(t, a) $ and $ \Lambda(t) $ converge to the positive steady states $ I^*(a) $ and $ \Lambda^* $, respectively. In particular, we can confirm that $ \Lambda^* = \gamma = 1 $ in Figure 3 (b).
For $ \tau = 4 > \tau_c $, we see in Figure 4 that the numerical solutions of $ I(t, a) $ and $ \Lambda(t) $ do not converge to the positive steady states but to positive periodic solutions.
Thus, we can conclude that a Hopf bifurcation occurs at $ \tau = \tau_c $. In this case, the outbreaks occur periodically if the length $ \tau $ of the period with no infectivity is sufficiently large.
We next consider the case where $ \Lambda^* \neq \gamma $. Let $ q: = \gamma - \Lambda^* \neq 0 $. Note that $ p-q = k+\mu+\Lambda^* > 0 $. As in the previous section, since we are interested in a Hopf bifurcation at which $ \mathrm{Re} \lambda = 0 $, we restrict our attention to $ \lambda $ such that $ \mathrm{Re} \lambda > \max (-p, -(p-q)) $ and $ \lambda \neq - q $. Equation (3.7) can then be rewritten as
$ 1=β1λ∫∞τe−(λ+p)a∫a0[(λ−Λ∗)e(λ+q)σ+Λ∗eqσ]dσda=β1λ∫∞τ[λ−Λ∗λ+q(e−(p−q)a−e−(λ+p)a)+Λ∗q(e−(λ+p−q)a−e−(λ+p)a)]da=β1λ[λ−Λ∗λ+q(e−(p−q)τp−q−e−(λ+p)τλ+p)+Λ∗q(e−(λ+p−q)τλ+p−q−e−(λ+p)τλ+p)]. $
|
(5.1) |
On the other hand, Eq (3.4) can be rewritten as
$ 1 = \beta_1 \int_\tau^\infty e^{-p a}\int_0^a e^{q \sigma} d\sigma da = \frac{\beta_1}{q} \int_\tau^\infty \left( e^{-(p-q) a} - e^{-pa} \right) da = \frac{\beta_1}{q} \left( \frac{e^{-(p-q)\tau}}{p-q} - \frac{e^{-p\tau}}{p} \right). $ |
Thus, we have
$ β1=pq(p−q)epτpeqτ−(p−q). $
|
(5.2) |
Let $ Q = Q(q, \tau) : = (e^{q\tau}-1)/q $. Note that $ Q(q, \tau) > 0 $ for all $ q \in \mathbb{R} \setminus \{ 0 \} $ and $ \tau > 0 $, and
$ \lim\limits_{q\to 0}Q(q, \tau) = \tau \ \ \mathrm{for \ each \ fixed \ } \tau > 0, \quad \lim\limits_{\tau \to 0} Q(q, \tau) = 0 \ \ \mathrm{for \ each \ fixed \ } q \neq 0. $ |
(5.2) can then be rewritten as
$ β1=p(p−q)epτpQ+1. $
|
(5.3) |
Substituting this $ \beta_1 $ into (5.1) and rearranging it, we obtain
$ (pQ+1)λ=p(p−q)[λ−Λ∗λ+q(eqτp−q−e−λτλ+p)+Λ∗q(e−(λ−q)τλ+p−q−e−λτλ+p)]=peqτλ−Λ∗λ+q+p(p−q)[−λ−Λ∗(λ+p)(λ+q)+Λ∗qeqτ(λ+p)−(λ+p−q)(λ+p)(λ+p−q)]e−λτ. $
|
We then have
$ \left( p Q + 1 \right) \lambda - p e^{q\tau} \frac{\lambda-\Lambda^*}{\lambda+q} + p(p-q) \left[ \frac{\lambda-\Lambda^*}{(\lambda+p)(\lambda+q)} - \frac{\Lambda^*}{q} \frac{e^{q\tau}(\lambda+p) - (\lambda + p - q)}{(\lambda+p)(\lambda+p-q)} \right] e^{-\lambda \tau} = 0. $ |
Multiplying by $ (\lambda+p)(\lambda+q) (\lambda + p-q) $ on both sides, we obtain
$ (pQ+1)λ(λ+p)(λ+q)(λ+p−q)−peqτ(λ−Λ∗)(λ+p)(λ+p−q)+p(p−q){(λ−Λ∗)(λ+p−q)+Λ∗q[(1−eqτ)λ+p−q−peqτ](λ+q)}e−λτ=0. $
|
Note that $ e^{q\tau} = qQ+1 $. We then have
$ (pQ+1)λ(λ+p)(λ+q)(λ+p−q)−p(qQ+1)(λ−Λ∗)(λ+p)(λ+p−q)+p(p−q){(λ−Λ∗)(λ+p−q)−Λ∗(Qλ+pQ+1)(λ+q)}e−λτ=0. $
|
It can be rewritten as
$ A4λ4+A3λ3+A2λ2+A1λ+A0+(B2λ2+B1λ+B0)e−λτ=0, $
|
(5.4) |
where
$ A4=pQ+1,A3=(2p−q)pQ+p,A2=[p(p−q)+Λ∗q]pQ+Λ∗p−(p−q)2,A1=−p(p−q)2+Λ∗(2p−q)p(qQ+1),A0=Λ∗p2(p−q)(qQ+1),B2=p(p−q)(1−Λ∗Q),B1=p(p−q)2−Λ∗p(p−q)(2+pQ+qQ),B0=−Λ∗p2(p−q)(qQ+1). $
|
We can check that (5.4) is equivalent to (4.4) if $ q \to 0 $. In fact, we have the following lemma:
Lemma 5.1. For each fixed $ \tau > 0 $, it holds that
$ limq→0(A4,A3,A2,A1,A0,B2,B1,B0)=(a4,a3,a2,a1,a0,b2,b1,b0). $
|
(5.5) |
Proof. For each fixed $ \tau > 0 $, recalling that $ \lim_{q\to 0}(Q, \Lambda^*) = (\tau, \gamma) $, we obtain
$ limq→0A4=pτ+1=a4,limq→0A3=2p2τ+p=a3,limq→0A2=p3τ+γp−p2=a2,limq→0A1=−p3+2γp2=a1,limq→0A0=γp3=a0,limq→0B2=p2(1−γτ)=b2,limq→0B1=p3−γp2(2+pτ)=b1,limq→0B0=−γp3=b0. $
|
This completes the proof.
By Proposition 4.3 and Lemma 5.1, regarding $ \tau $ as a bifurcation parameter, we see that a Hopf bifurcation can occur as in Section 4 if $ |q| $ is sufficiently small. More precisely, we obtain the following corollary:
Corollary 5.1. Suppose that $ q\neq 0 $, $ |q| $ is sufficiently small, and $ \beta_1 $ depends on $ \tau $ as for (5.3). Then, $ {\cal R}_0 > 1 $ and $ \Lambda^* = \gamma-q > 0 $ hold for all $ \tau \geq 0 $, and there exists a $ \tau_c > 0 $ such that a pair of simple pure imaginary roots $ \pm i \Omega(\tau_c) \left( = \pm i \Omega_c \right) $ satisfies the characteristic Eq (5.4) and crosses the imaginary axis from left to right as $ \tau $ increases over $ \tau_c $.
We next proceed to a more general case where $ |q| $ is not small. We can prove the following lemma, which corresponds to Lemma 4.1.
Lemma 5.2. If $ \tau = 0 $, then all roots $ \lambda $ except $ 0 $ and $ -q $ of the characteristic Eq (5.4) have negative real parts.
Proof. If $ \tau = 0 $, then $ Q = 0 $, and the characteristic Eq (5.4) can be rewritten as
$ \lambda^4 + p \lambda^3 + [q (p-q) + \Lambda^* p ] \lambda^2 + \Lambda^* pq \lambda = 0. $ |
This equation is equivalent to
$ \lambda (\lambda + q) \left[ \lambda^2 + r \lambda + \Lambda^* p \right] = 0. $ |
If $ \lambda \neq 0, -q $, then we have
$ \lambda^2 + (p-q) \lambda + \Lambda^* p = 0. $ |
We then see that all roots $ \lambda $ have negative real parts because $ p-q > 0 $ and $ \Lambda^* p > 0 $. This completes the proof.
Using Lemma 5.2, we prove the following proposition on the local asymptotic stability of $ E^* $ for $ \tau = 0 $:
Proposition 5.1. If $ {\cal R}_0 > 1 $, $ q\neq 0 $ and $ \tau = 0 $, then the endemic equilibrium $ E^* $ of system (2.2) is locally asymptotically stable.
Proof. By Lemma 5.2, it suffices to show that $ \lambda = 0 $ and $ -q $ do not affect the stability of $ E^* $. In fact, by Lemma 3.1, $ \lambda = 0 $ cannot be a characteristic eigenvalue. If $ q > 0 $, then $ \lambda = -q $ does not affect the stability of the endemic equilibrium $ E^* $. If $ q < 0 $, substituting $ \lambda = -q $ into the first equation in (5.1), we obtain, for $ \tau = 0 $,
$ 1=β1−q∫∞0e−(p−q)a[−(q+Λ∗)a+Λ∗q(eqa−1)]da=β1γq∫∞0ae−(p−q)ada+β1Λ∗q2∫∞0[e−(p−q)a−e−(p−2q)a]da=β1γq1(p−q)2+β1Λ∗q2(1p−q−1p−2q)=β1q(p−q)(γp−q−Λ∗p−2q)=β1(p−q−γ)(p−q)2(p−2q). $
|
Since $ \beta_1 = p (p-q) $ for $ \tau = 0 $, we have
$ 1 = \frac{p(p-q-\gamma)}{(p-q)(p-2q)} < \frac{(p-2q) (p-q)}{(p-q)(p-2q)} = 1, $ |
which is a contradiction (note that $ p < p-2q $ as $ q < 0 $). Hence, $ \lambda \neq -q $. This completes the proof.
As in Section 4.1, substituting $ \lambda = i\Omega \ (\Omega > 0) $ into (5.4), we obtain
$ A_4 \Omega^4 - i A_3 \Omega^3 - A_2 \Omega^2 + i A_1\Omega + A_0 +(-B_2\Omega^2 + i B_1\Omega + B_0) e^{-i\Omega \tau} = 0. $ |
Dividing this equation into real and imaginary parts, we have
$ {A4Ω4−A2Ω2+A0=(B2Ω2−B0)cosΩτ−B1ΩsinΩτ,A3Ω3−A1Ω=B1ΩcosΩτ+(B2Ω2−B0)sinΩτ. $
|
(5.6) |
Taking squares of both sides in the two equations and adding them, we obtain
$ (A_4\Omega^4 - A_2\Omega^2 + A_0)^2 + (A_3\Omega^3 - A_1 \Omega)^2 = (B_2\Omega^2-B_0)^2 +B_1^2 \Omega^2. $ |
Rearranging this equation, we have
$ Ω2[C3(Ω2)3+C2(Ω2)2+C1Ω2+C0]=0 $
|
(5.7) |
(note that $ A_0^2-B_0^2 = 0 $), where
$ C_3 = A_4^2, \ \ C_2 = -2 A_2 A_4 + A_3^2, \ \ C_1 = 2A_0A_4 + A_2^2 - 2A_1A_3 - B_2^2, \ \ C_0 = -2A_0 A_2 + A_1^2 + 2B_0 B_2-B_1^2. $ |
By Lemma 3.1, we can rule out $ \Omega = 0 $. Hence, we obtain
$ C3(Ω2)3+C2(Ω2)2+C1Ω2+C0=0. $
|
(5.8) |
As in Section 4.1, we define $ H(x): = C_3x^3+C_2x^2+C_1x+C_0 $. If $ H(x) = 0 $ has a positive root $ x^* > 0 $, then $ \Omega = \sqrt{x^*} $ satisfies (5.7). To find such $ x^* $, we investigate the signs of coefficients in (5.8). We prove the following lemma:
Lemma 5.3. $ C_2 > 0 $ and $ C_3 > 0 $ for all $ \tau \geq 0 $.
Proof. It is obvious that $ C_3 = (pQ+1)^2 \geq 1 > 0 $ for all $ \tau \geq 0 $. On $ C_2 $, we have
$ C2=−2A2A4+A23=−2{[p(p−q)+Λ∗q]pQ+Λ∗p−(p−q)2}(pQ+1)+[(2p−q)pQ+p]2=−2{p2(p−q)Q−(p−q)2}(pQ+1)−2Λ∗p(qQ+1)(pQ+1)+[(2p−q)pQ+p]2. $
|
(5.9) |
Recalling that $ p-q = k + \mu + \Lambda^* > \Lambda^* $ and $ qQ+1 = e^{q\tau } > 0 $, we obtain
$ C2>−2{p2(p−q)Q−(p−q)2}(pQ+1)−2(p−q)p(qQ+1)(pQ+1)+[(2p−q)pQ+p]2={−2[p(p−q)+(p−q)q]+(2p−q)2}(pQ)2+{−2[p(p−q)+(p−q)(p+q)−(p−q)2]+2p(2p−q)}pQ−2[p(p−q)−(p−q)2]+p2=[2(p−q)2+q2](pQ)2+2[(p−q)2+q2]pQ+(p−q)2+q2≥(p−q)2+q2>0, $
|
(5.10) |
for all $ \tau \geq 0 $. This completes the proof.
By Lemma 5.3, if $ C_0 < 0 $ for all $ \tau \geq 0 $, then a similar argument as in the proof of Lemma 4.2 gives the existence of the unique $ \Omega > 0 $ satisfying (5.8). However, unlike the case of $ \Lambda^* = \gamma $ in Section 4, $ C_0 < 0 $ for all $ \tau \geq 0 $ does not hold in general. To clarify this point, we investigate a special case where the following additional condition is satisfied:
(A6) $ \gamma \gg k + \mu $.
For example, if the reduction rate $ k $ of infectivity is small, then (A6) is not so unrealistic because, in many human infectious diseases, the infection period is much shorter than the average life span (that is, $ \gamma \gg \mu $). Under assumption (A6), $ p \approx \gamma $, and coefficients in (5.4) can be rewritten as
$ A4=γQ+1,A3=(2γ−q)γQ+γ,A2=[γ(γ−q)+Λ∗q]γQ+Λ∗γ−(γ−q)2=(γ−q)[(γ+q)γQ+γ−(γ−q)]=(γ−q)[(γ+q)γQ+q],A1=−γ(γ−q)2+Λ∗(2γ−q)γ(qQ+1)=(γ−q)[−γ(γ−q)+(2γ−q)γ(qQ+1)]=γ(γ−q)2qQ+(γ−q)γ2(qQ+1),A0=(γ−q)2γ2(qQ+1),B2=γ(γ−q)(1−Λ∗Q)=(γ−q)[γ−(γ−q)γQ],B1=γ(γ−q)2−Λ∗γ(γ−q)[2+(γ+q)Q]=γ(γ−q)2[−1+(γ+q)Q],B0=−A0 $
|
(note that $ \Lambda^* = \gamma-q > 0 $). We next prove the following lemma on the sign of $ C_0 $:
Lemma 5.4. Suppose that (A6) holds. Then, the following properties hold:
(ⅰ) If $ |q| < \gamma/\sqrt{2} $, then $ C_0 < 0 $ for all $ \tau \geq 0 $. In particular, $ C_0 $ is monotone decreasing for $ \tau \geq 0 $.
(ⅱ) If $ q > (\sqrt{3}-1) \gamma $ or $ q < -(\sqrt{3}+1) \gamma $, then $ C_0 > 0 $ for all $ \tau \geq 0 $. In particular, $ C_0 $ is monotone increasing for $ \tau \geq 0 $.
Proof. Under assumption (A6), $ C_0 $ can be calculated as
$ C0=−2A0(A2+B2)+A21−B21=−2(γ−q)3γ2(qQ+1)(2qγQ+q+γ)+γ2(γ−q)2{[(γ−q)qQ+γ(qQ+1)]2−(γ−q)2[(γ+q)Q−1]2}=γ2(γ−q)2{2(q−γ)[2q2γQ2+(q2+3qγ)Q+(q+γ)]+(6γ2q2−4γq3−γ4)Q2+(−2γ3+6γ2q−2q3)Q+2qγ−q2}=γ2(γ−q)2[(2q2−γ2)(γQ)2+2(2q2−γ2)γQ+(q+γ)2−3γ2]. $
|
(5.11) |
If $ |q| < \gamma/\sqrt{2} $, then $ 2q^2-\gamma^2 < 0 $, and thus,
$ C_0 < \gamma^2 (\gamma-q)^2 [(q+\gamma)^2 -3 \gamma^2] = \gamma^2 (\gamma-q)^2 \left[ q- (\sqrt{3}-1)\gamma \right] \left[ q+(\sqrt{3}+1)\gamma \right] < 0, $ |
for all $ \tau \geq 0 $ (note that $ \sqrt{3}+1 > \sqrt{3}-1 > 1/\sqrt{2} $). The second assertion follows from (5.11) and the fact that $ \partial Q/\partial \tau = e^{q\tau} > 0 $. This proves (ⅰ).
If $ q > (\sqrt{3}-1)\gamma $ or $ q < -(\sqrt{3}+1)\gamma $, then $ 2q^2-\gamma^2 > 0 $ (note that $ \sqrt{3}-1 > 1/\sqrt{2} $), and thus,
$ C_0 > \gamma^2 (\gamma-q)^2 [(q+\gamma)^2 -3 \gamma^2] = \gamma^2 (\gamma-q)^2 \left[ q- (\sqrt{3}-1)\gamma \right] \left[ q+(\sqrt{3}+1)\gamma \right] > 0, $ |
for all $ \tau \geq 0 $. The second assertion follows in a similar way as in (ⅰ). This proves (ⅱ).
Figure 5 shows an example of each case in Lemma 5.4. $ (k, \mu, \gamma) = (0.01, 0.01, 1) $ is fixed so that $ \gamma \gg k+\mu $. In Figure 5(a), $ q = 0.95\gamma/\sqrt{2} $, and hence, $ |q| < \gamma/\sqrt{2} $ holds. In this case, as stated in Lemma 5.4 (ⅰ), we can check that $ C_0 = H(0) $ is negative and monotone decreasing for each $ \tau \geq 0 $. By Lemma 5.3, as in Lemma 4.2, there always exists a unique $ x^* > 0 $ such that $ H(x^*) = 0 $, and hence, $ \Omega = \sqrt{x^*} $ satisfies (5.8). In addition, one can see that $ H'(x^*) > 0 $.
On the other hand, in Figure 5(b), $ q = 1.1(\sqrt{3}-1) \gamma > (\sqrt{3}-1) \gamma $. As stated in Lemma 5.4 (ⅱ), we can check that $ C_0 = H(0) $ is positive and monotone increasing for each $ \tau \geq 0 $. As shown in this figure, there can exist two positive numbers $ x_+^* > 0 $ and $ x_-^* > 0 $ ($ x_+^* > x_-^* $) such that $ H(x_\pm^*) = 0 $. In this case, (5.8) has two positive solutions $ \Omega = \sqrt{x_\pm^*} $. In addition, one can see that $ H'(x_+^*) > 0 $ and $ H'(x_-^*) < 0 $.
Note that, as in Section 4, (5.8) is a necessary condition for $ \lambda = \pm i\Omega $ to be a pair of simple pure imaginary roots of the characteristic Eq (5.4). From (5.6), we have
$ {cosΩτ=(A4Ω4−A2Ω2+A0)(B2Ω2−B0)+(A3Ω3−A1Ω)B1Ω(B2Ω2−B0)2+B21Ω2=:Φ,sinΩτ=−(A4Ω4−A2Ω2+A0)B1Ω+(A3Ω3−A1Ω)(B2Ω2−B0)(B2Ω2−B0)2+B21Ω2=:Ψ, $
|
(5.12) |
and define $ \Theta \in (0, 2\pi] $ by
$ \Theta : = \left\{ arccosΦ,Ψ>0,2π−arccosΦ,Ψ≤0. \right. $
|
It then follows from (5.12) that $ \Omega \tau = \Theta $. For each $ \tau \geq 0 $, let $ F(\tau): = \Theta(\tau)/\Omega(\tau) $. Our aim is then to show the existence of a positive fixed point $ F(\tau_c) = \tau_c > 0 $, which implies that $ \lambda = \pm i \Omega(\tau_c) $ is a pair of simple pure imaginary roots of the characteristic Eq (5.4). To this end, we now show the following lemma:
Lemma 5.5. Suppose that (A6) holds. For coefficients $ C_0, C_1, C_2 $ and $ C_3 $, it holds that
$ \lim\limits_{\tau \to \infty} \frac{1}{(\gamma Q)^2} \left( C0C1C2C3 \right) = \left( γ2(γ−q)2(2q2−γ2)−2(γ−q)[(γ−q)γq+q3]2(γ−q)2+q21 \right). $
|
Proof. Note that $ \lim_{\tau \to \infty} Q = \infty $. It then follows that
$ \lim\limits_{\tau \to \infty} \frac{C_3}{(\gamma Q)^2} = \lim\limits_{\tau \to \infty} \frac{(\gamma Q + 1)^2}{(\gamma Q)^2} = 1. $ |
From (5.11), it follows that
$ \lim\limits_{\tau \to \infty} \frac{C_0}{(\gamma Q)^2} = \lim\limits_{\tau \to \infty} \gamma^2 (\gamma-q)^2 \left[ (2q^2-\gamma^2) + \frac{2(2q^2-\gamma^2)}{\gamma Q} + \frac{(q+\gamma)^2 - 3\gamma^2}{(\gamma Q)^2} \right] = \gamma^2 (\gamma-q)^2 (2q^2-\gamma^2). $ |
Moreover, replacing $ p $ and $ \Lambda^* $ in (5.9) by $ \gamma $ and $ \gamma-q $, respectively, we can perform a similar calculation as in (5.10) and obtain
$ \lim\limits_{\tau \to \infty} \frac{C_2}{(\gamma Q)^2} = \lim\limits_{\tau \to \infty} \left[ 2(\gamma-q)^2 + q^2 + \frac{2 (\gamma -q)^2 + 2 q^2 }{\gamma Q} + \frac{(\gamma -q)^2 + q^2}{(\gamma Q)^2} \right] = 2 (\gamma -q)^2 + q^2. $ |
For $ C_1 $, we have
$ C1=2A0A4+A22−2A1A3−B22=2(γ−q)2γ2(qQ+1)(γQ+1)+(γ−q)2[(γ+q)γQ+q]2−2γ(γ−q)[(γ−q)qQ+γ(qQ+1)][(2γ−q)γQ+γ]−(γ−q)2[γ−(γ−q)γQ]2=2(γ−q)γ2(qQ+1)[(γ−q)(γQ+1)−(2γ−q)γQ−γ]+(γ−q)2[4γq(γQ)2+2(γ2+q2)γQ+q2−γ2]−2(γ−q)2qγQ[(2γ−q)γQ+γ]=−2(γ−q)γ2(qQ+1)(γ2Q+q)+(γ−q)2[4γq(γQ)2+2(γ2+q2)γQ+q2−γ2]−2(γ−q)2qγQ[(2γ−q)γQ+γ]=2(γ−q)[−γ2q+2(γ−q)γq−(γ−q)q(2γ−q)](γQ)2+2(γ−q)[−(q2+γ2)γ+(γ−q)(γ2+q2)−(γ−q)qγ]γQ+(γ−q)[−2γ2q+(γ−q)(q2−γ2)]=−2(γ−q)[(γ−q)γq+q3](γQ)2−2(γ−q)[(γ−q)γq+(γ2+q2)q]γQ−(γ−q)[(γ−q)γq+γ3+q3]. $
|
We then have $ \lim_{\tau \to \infty} C_1/ (\gamma Q)^2 = -2(\gamma -q) [(\gamma-q) \gamma q + q^3] $. This completes the proof.
Using Lemmas 5.3–5.5, we prove the following proposition on the existence of a pair of simple pure imaginary roots for $ |q| < \gamma/\sqrt{2} $:
Proposition 5.2. Suppose that (A6) holds, and $ |q| < \gamma/\sqrt{2} $. Then, there exists a $ \tau_c > 0 $ such that $ \lambda = \pm i \Omega(\tau_c) $ is a pair of simple pure imaginary roots of the characteristic Eq (5.4).
Proof. By Lemmas 5.3 and 5.4, for each $ \tau \geq 0 $, the positive $ \Omega(\tau) > 0 $ uniquely exists. Hence, we have $ F(0) = \Theta(0)/\Omega(0) > 0 $. As in the proof of Proposition 4.1, by the continuity, it suffices to show that $ \lim_{\tau \to \infty}F(\tau) < \infty $.
Let $ \{ \tau_n \}_{n = 1}^\infty $ be an increasing sequence in $ (0, \infty) $, and let $ \Omega_n : = \Omega(\tau_n) $ and $ Q_n : = Q(\cdot, \tau_n) $. By dividing both sides of (5.8) by $ (\gamma Q_n)^2 $, we have
$ \frac{C_3}{(\gamma Q_n)^2} (\Omega^2_n)^3 + \frac{C_2}{(\gamma Q_n)^2} (\Omega^2_n)^2 + \frac{C_1}{(\gamma Q_n)^2} \Omega^2_n + \frac{C_0}{(\gamma Q_n)^2} = 0. $ |
By Lemma 5.5, we see that $ \{ \Omega_n \}_{n = 1}^\infty $ converges to $ \Omega_\infty $, which is the unique positive root of the following equation:
$ (\Omega_\infty^2)^3 + [2(\gamma-q)^2 + q^2] (\Omega_\infty^2)^2 -2 (\gamma-q) [(\gamma-q)\gamma q + q^3] \Omega_\infty^2 + \gamma^2 (\gamma-q)^2 (2q^2-\gamma^2) = 0. $ |
Thus, we have $ \lim_{\tau \to \infty}F(\tau) \leq 2\pi/\Omega_\infty < \infty $. This completes the proof.
For $ q > (\sqrt{3}-1) \gamma $ or $ q < -(\sqrt{3}+1)\gamma $, by Lemma 5.4 (ⅱ), $ C_0 > 0 $ for all $ \tau \geq 0 $, and hence, $ H(x) = 0 $ may have multiple positive roots $ x_\pm^* > 0 $ such that $ H'(x_+^*) > 0 $ and $ H'(x_-^*) < 0 $ (see Figure 5(b)). In this case, it seems difficult to show analytically the existence of a pair of simple pure imaginary roots. Instead, we will investigate it numerically in Section 5.3.
As in Section 4.2, we investigate the transversality condition of a Hopf bifurcation. Let $ G(\tau) : = \tau - F(\tau) $.
Lemma 5.6. Suppose that there exists a $ \tau_c > 0 $ such that $ G(\tau_c) = 0 $. Then, the characteristic Eq (5.4) has a pair of simple pure imaginary roots $ \lambda = \pm i \Omega(\tau_c) = \pm i \Omega_c $, and
$ sign{dReλdτ|λ=iΩc}=sign{H′(Ω2c)}sign{G′(τc)}. $
|
(5.13) |
Proof. As in the proof of Proposition 4.2, we have
$ sign{dReλdτ|λ=iΩc}=sign{∂Y(Ωc)∂ω} sign{G′(τc)}, $
|
(5.14) |
where $ Y(\Omega) $ is defined by the left-hand side of (5.7):
$ Y(\Omega) : = \Omega^2 [C_3(\Omega^2)^3 + C_2(\Omega^2)^2 + C_1\Omega^2 + C_0] = \Omega^2 H(\Omega^2). $ |
Now, we have
$ \frac{\partial Y (\Omega_c)}{\partial \omega} = 2 \Omega_c^2 H(\Omega_c^2) + \Omega_c^2 H'(\Omega_c^2) 2\Omega_c = 2\Omega_c^3 H'(\Omega_c^2) $ |
(note that $ H(\Omega_c^2) = 0 $). As $ \Omega_c^3 > 0 $, we then have
$ \mathrm{sign} \left\{ \frac{\partial Y (\Omega_c)}{\partial \omega} \right\} = \mathrm{sign} \left\{ H'(\Omega_c^2) \right\}, $ |
and hence, (5.13) follows from (5.14). This completes the proof.
In the case of Lemma 5.4 (ⅰ), $ H(x) = 0 $ has only one positive root $ x^* > 0 $ such that $ H'(x^*) > 0 $ (see Figure 5(a)). Therefore, by Lemma 5.6, we see that if $ \lambda = \pm i \Omega_c = \pm i \sqrt{x^*} $ is a pair of simple pure imaginary roots of (5.4), then it crosses the imaginary axis from left to right. This together with Lemma 5.4 (ⅰ) and Proposition 5.2 gives the following main theorem:
Theorem 5.1. Suppose that (A6) holds, $ q\neq 0 $, and $ |q| < \gamma/\sqrt{2} $. If $ \beta_1 $ depends on $ \tau $ as for (5.3), then $ {\cal R}_0 > 1 $ and $ \Lambda^* = \gamma-q > 0 $ hold for all $ \tau \geq 0 $, and there exists a $ \tau_c > 0 $ such that a pair of simple pure imaginary roots $ \pm i \Omega(\tau_c) \left( = \pm i \Omega_c \right) $ satisfies the characteristic Eq (5.4) and crosses the imaginary axis from left to right as $ \tau $ increases over $ \tau_c $.
Under the condition in Theorem 5.1, there always exists a critical value $ \tau_c > 0 $ such that a Hopf bifurcation occurs, and a periodic solution arises at $ \tau = \tau_c $. Note that, under assumption (A6), "sufficiently small $ |q| $" in Corollary 5.1 is improved to the inequality $ |q| < \gamma/\sqrt{2} $ in Theorem 5.1. For the case of Lemma 5.4 (ⅱ), we have the following remark:
Remark 5.1. In the case of Lemma 5.4 (ii), $ H(x) = 0 $ may have two positive roots $ x_+^* > x_-^* > 0 $ such that $ H'(x_+^*) > 0 > H'(x_-^*) $ (see Figure 5(b)). Therefore, by Lemma 5.6, we see that if $ \lambda = \pm i \Omega_c = \pm i \sqrt{x_+^*} $ (resp. $ \pm i\sqrt{x_-^*} $) is a pair of simple pure imaginary roots of (5.4), then it crosses the imaginary axis from left to right (resp. from right to left). In other words, $ \lambda = \pm i \sqrt{x_+^*} $ (resp. $ \pm i \sqrt{x_-^*} $) can lead to the destabilization (resp. stabilization) of the endemic equilibrium $ E^* $.
In other words, in the case of Lemma 5.4 (ⅱ), the stability switch of the endemic equilibrium $ E^* $ can occur more than once. We numerically confirm this point in the next subsection.
Fix the following parameters:
$ k = \mu = 0.05, \quad \gamma = 10, \quad p = 10.1 \left( = k+\mu+\gamma \right). $ |
Note that they are chosen for a technical reason to confirm the validity of Theorem 5.1 and Remark 5.1, and there is no biological justification. We can regard $ \gamma \gg k + \mu $, and thus, assumption (A6) holds. For each $ q \in (-\infty, 0) \cup (0, \gamma) $ and $ \tau \geq 0 $, set $ \beta_1 $ as (5.3). Then, $ {\cal R}_0 > 1 $, and $ \Lambda^* = \gamma - q > 0 $ holds. To investigate the stability of the endemic equilibrium $ E^* $, set the initial condition as
$ S(0, a) = S^*(a) = e^{-\Lambda^* a}, \quad I(0, a) = 0.9 I^*(a) = 0.9 \frac{\Lambda^*}{q} (e^{-\Lambda^* a} - e^{-\gamma a}), \quad a \geq 0. $ |
First, set $ q = 0.95 \gamma/\sqrt{2} \approx 6.7175 $. In this case, by Theorem 5.1, there exists a $ \tau_c > 0 $ such that a Hopf bifurcation occurs. In fact, we can calculate $ \tau_c \approx 0.446 $ (see Figure 6(a)).
Figure 7(a) and (b) show that, for $ \tau = 0.4 < \tau_c $, $ I(t, a) $ and $ \Lambda(t) $ converge to the steady states $ I^*(a) $ and $ \Lambda^* = \gamma -q \approx 3.2825 $, respectively.
On the other hand, Figure 7(c) and (d) show that, for $ \tau = 0.5 > \tau_c $, $ I(t, a) $ and $ \Lambda(t) $ converge to positive periodic solutions. This indicates that a Hopf bifurcation occurs at $ \tau = \tau_c $.
Next, set $ q = 1.36(\sqrt{3}-1) \gamma \approx 9.9559 $. In this case, by Lemma 5.4 (ⅱ), $ C_0 > 0 $ for all $ \tau \geq 0 $, and hence, $ H(x) = 0 $ may have two positive roots $ x_+^* > x_-^* > 0 $ such that $ H'(x^*_+) > 0 > H'(x_-^*) $. As stated in Remark 5.1, $ \lambda = \pm i \sqrt{x^*_+} $ (resp. $ \pm i \sqrt{x_-^*} $) can lead to the destabilization (resp. stabilization) of the endemic equilibrium $ E^* $. To clarify this point, let $ F_+(\tau) $ and $ G_+(\tau) $ (resp. $ F_-(\tau) $ and $ G_-(\tau) $) be $ F(\tau) $ and $ G(\tau) $ corresponding to $ \Omega(\tau) = \sqrt{x_+^* (\tau)} $ (resp. $ \sqrt{x_-^*(\tau)} $), respectively. If there exists a $ \tau_+ > 0 $ (resp. $ \tau_- > 0 $) such that $ G_+ (\tau_+) = 0 $ (resp. $ G_- (\tau_-) = 0 $), then the destabilization (resp. stabilization) of the endemic equilibrium $ E^* $ can occur at $ \tau = \tau_+ $ (resp. $ \tau_- $). In fact, we can compute $ F_\pm (\tau) $ and $ G_\pm (\tau) $ as shown in Figure 6(b) and obtain $ \tau_+ \approx 2.55 $ and $ \tau_- \approx 8.7 $. That is, we can predict that the endemic equilibrium $ E^* $ is stable for $ \tau \in [0, \tau_+) $, is unstable for $ \tau \in (\tau_+, \tau_-) $ and becomes stable again when $ \tau $ increases over $ \tau_- $. Indeed, in Figure 8(a), the force of infection $ \Lambda(t) $ converges to the positive steady state $ \Lambda^* = \gamma-q \approx 0.0441 $ for $ \tau = 2 < \tau_+ $, whereas in Figure 8(b), $ \tau = 3 > \tau_+ $, and $ \Lambda(t) $ converges to a periodic solution.
In Figure 8(c), for $ \tau = 8.2 < \tau_- $, $ \Lambda(t) $ converges to a periodic solution, whereas in Figure 8(d), for $ \tau = 9.2 > \tau_- $, $ \Lambda(t) $ converges to the positive steady state. That is, the stability switch of the endemic equilibrium $ E^* $ occurs twice at $ \tau = \tau_+ $ and $ \tau_- $.
In this paper, we have studied the local stability of the endemic equilibrium in a chronological age-structured SIR epidemic model with age-dependent infectivity. We assumed that the transmission rate is a shifted exponential function and investigated the possibility of a Hopf bifurcation regarding the infimum of the support of the transmission rate as a bifurcation parameter. We have shown that, if the distance between the force of infection at the endemic equilibrium and the removal rate is zero or sufficiently small ($ |q| \ll 1 $), then there always exists a critical value of the bifurcation parameter at which a Hopf bifurcation occurs. Furthermore, in a special case where the removal rate is sufficiently larger than the sum of the mortality rate and the reduction rate of infectivity, we have obtained a specific inequality ($ |q| < \gamma/\sqrt{2} $) for which a similar critical value for a Hopf bifurcation always exists. We have performed numerical simulations and observed bifurcations of a stable periodic solution from the endemic equilibrium. On the other hand, for the case where $ q > (\sqrt{3}-1)\gamma $, we have numerically confirmed that the stability switch of the endemic equilibrium can occur multiple times.
Our results have given a partial answer to a question of the possibility of a Hopf bifurcation in a chronological age-structured SIR epidemic model with age-dependent infectivity, which was raised in [15]. As our results are restricted to a special case where the transmission rate is a shifted exponential function, the study of other cases would be interesting future work. In particular, although we disregarded the age-dependent susceptibility for the sake of simplicity in the analysis, it would make the model more realistic because the assumption of the shifted exponential function could be suitable for some sexually transmitted diseases for which people under a certain age do not have the infectivity and susceptibility. It is an open problem whether a Hopf bifurcation still occurs if we introduce the age-dependent susceptibility to our model. Although it might be easily checked by numerical simulations, the analytical proof may be a more challenging task because it may be difficult to obtain a concrete characteristic equation like (4.4) when the force of infection depends on the age of the susceptible population.
Although our work in this paper was motivated by the mathematical analysis, periodic solutions in autonomous systems like our model could help in understanding the mechanism of the non-seasonal recurrent outbreaks which have been observed in many diseases such as measles. The application of our results to epidemiological considerations would also be important future work.
We deeply appreciate the editor and the anonymous referees for their valuable and constructive comments that helped us to improve the manuscript. T. Kuniya was supported by the Japan Society for the Promotion of Science (JSPS) [grant numbers 19K14594, 23K03214]. H. Inaba was supported by the Japan Society for the Promotion of Science (JSPS) [grant number 22K03433].
The authors declare there is no conflict of interest.
[1] | American Psychiatric Association (2013) Autism spectrum disorder, 299.00 (F84.0), In: Diagnostic and Statistical Manual of Mental Disorders, 5 Eds., American Psychiatric Publishing, 50–59. |
[2] |
Hallmayer J, Cleveland S, Torres A, et al. (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68: 1095–1102. doi: 10.1001/archgenpsychiatry.2011.76
![]() |
[3] |
Schultz ST, Klonoff-Cohen HS, Wingard DL, et al. (2008) Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: The results of a parent survey. Autism 12: 293–307. doi: 10.1177/1362361307089518
![]() |
[4] |
Becker KG, Schultz ST (2010) Similarities in features of autism and asthma and a possible link to acetaminophen use. Med Hypotheses 74: 7–11. doi: 10.1016/j.mehy.2009.08.033
![]() |
[5] | Orlowski JP, Hanhan UA, Fiallos MR (2002) Is aspirin a cause of Reye's syndrome? A case against. Drug Saf 25: 225–231. |
[6] | Avella-Garcia CB, Julvez J, Fortuny J, et al. (2016) Acetaminophen use in pregnancy and neurodevelopment: Attention function and autism spectrum symptoms. Int J Epidemiol 45: 1987–1996. |
[7] |
Liew Z, Ritz B, Virk J, et al. (2016) Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study. Autism Res 9: 951–958. doi: 10.1002/aur.1591
![]() |
[8] |
Masarwa R, Levine H, Gorelik E, et al. (2018) Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: A systematic review, meta-analysis, and meta-regression analysis of cohort studies. Am J Epidemiol 187: 1817–1827. doi: 10.1093/aje/kwy086
![]() |
[9] | Schultz ST (2010) Can autism be triggered by acetaminophen activation of the endocannabinoid system? Acta Neurobiol Exp 70: 227–231. |
[10] | Schultz ST, Gould GG (2016) Acetaminophen use for fever in children associated with autism spectrum disorder. Autism Open Access 6: 170. |
[11] | Bertolini A, Ferrari A, Ottani A, et al. (206) Paracetamol: New vistas of an old drug. CNS Drug Rev 12: 250–275. |
[12] |
Mallet C, Daulhac L, Bonnefont J, et al. (2008) Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 139: 190–200. doi: 10.1016/j.pain.2008.03.030
![]() |
[13] |
Gould GG, Seillier A, Weiss G, et al. (2012) Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Prog Neuropsychopharmacol Biol Psychiatry 38: 260–269. doi: 10.1016/j.pnpbp.2012.04.011
![]() |
[14] |
Chakrabarti B, Persico A, Battista N, et al. (2015) Endocannabinoid signaling in autism. Neurotherapeutics 12: 837–847. doi: 10.1007/s13311-015-0371-9
![]() |
[15] |
Barchel D, Stolar O, De-Haan T, et al. (2019) Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Front Pharmacol 9: 1521. doi: 10.3389/fphar.2018.01521
![]() |
[16] |
Poleg S, Golubchik P, Offen D, et al. (2019) Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry 89: 90–96. doi: 10.1016/j.pnpbp.2018.08.030
![]() |
[17] | Zamberletti E, Gabaglio M, Parolaro D (2017) The endocannabinoid system and autism apectrum disorders: Insights from animal models. Int J Mol Sci 18: pii: E1916. |
[18] | Hosie S, Malone DT, Liu S, et al. (2018) Altered amygdala excitation and CB1 receptor modulation of aggressive behavior in the neuroligin-3R451C mouse model of autism. Front Cell Neurosci 12: 234. |
[19] |
Melancia F, Schiavi S, Servadio M, et al. (2018) Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling. Br J Pharmacol 175: 3699–3712. doi: 10.1111/bph.14435
![]() |
[20] | Kuo HY, Liu FC (2018) Molecular pathology and pharmacological treatment of autism spectrum disorder-like phenotypes using rodent models. Front Cell Neurosci 12: 422. |
[21] |
Kerr DM, Downey L, Conboy M, et al. (2013) Alterations in the endocannabinoid system in the rat valproic acid model of autism. Behav Brain Res 249: 124–132. doi: 10.1016/j.bbr.2013.04.043
![]() |
[22] |
Kerr DM, Gilmartin A, Roche M (2016) Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. Pharm Res 113: 228–235. doi: 10.1016/j.phrs.2016.08.033
![]() |
[23] |
Siniscalco D, Sapone A, Giordano C, et al. (2013) Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord 43: 2686–2695. doi: 10.1007/s10803-013-1824-9
![]() |
[24] | Brigida AL, Schultz S, Cascone M, et al. (2017) Endocannabinoid signal dysregulation in autism spectrum disorders: A correlation link between inflammatory state and neuro-immune alterations. Int J Mol Sci 18: pii: E1425. |
[25] |
Karhson DS, Krasinska KM, Dallaire JA, et al. (2018) Plasma anandamide concentrations are lower in children with autism spectrum disorder. Mol Autism 9: 18. doi: 10.1186/s13229-018-0203-y
![]() |
[26] |
Aran A, Eylon M, Harel M, et al. (2019) Lower circulating endocannabinoid levels in children with autism spectrum disorder. Mol Autism 10: 2. doi: 10.1186/s13229-019-0256-6
![]() |
[27] |
Leweke FM, Piomelli D, Pahlisch F, et al. (2012) Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2: e94. doi: 10.1038/tp.2012.15
![]() |
[28] |
Bar-Lev Schleider L, Mechoulam R, Saban N, et al. (2019) Real life experience of medical cannabis treatment in autism: Analysis of safety and efficacy. Sci Rep 9: 200. doi: 10.1038/s41598-018-37570-y
![]() |
[29] | Siniscalco D, Schultz S, Brigida AL, et al. (2018) Inflammation and neuro-immune dysregulations in autism spectrum disorders. Pharmaceuticals (Basel) 11: pii: E56. |
[30] |
Watson S, Chambers D, Hobbs C, et al. (2008) The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation. Mol Cell Neurosci 38: 89–97. doi: 10.1016/j.mcn.2008.02.001
![]() |
[31] |
Zikopoulos B, Liu X, Tepe J, et al. (2018) Opposite development of short- and long-range anterior cingulate pathways in autism. Acta Neuropathol 136: 759–778. doi: 10.1007/s00401-018-1904-1
![]() |
[32] |
Soltys J, Yushak M, Mao-Draayer Y (2010) Regulation of neural progenitor cell fate by anandamide. Biochem Biophys Res Commun 400: 21–26. doi: 10.1016/j.bbrc.2010.07.129
![]() |
[33] |
Campos AC, Ortega Z, Palazuelos J, et al. (2013) The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system. Int J Neuropsychopharmacol 16: 1407–1419. doi: 10.1017/S1461145712001502
![]() |
[34] |
Khan AA, Shekh-Ahmad T, Khalil A (2018) Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model. Br J Pharmacol 175: 2097–2115. doi: 10.1111/bph.14202
![]() |
[35] |
Couch DG, Tasker C, Theophilidou E, et al. (2017) Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. Clin Sci (Lond) 131: 2611–2626. doi: 10.1042/CS20171288
![]() |
[36] |
D'Argenio G, Valenti M, Scaglione G, et al. (2006) Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 20: 568–570. doi: 10.1096/fj.05-4943fje
![]() |
[37] | Sales AJ, Fogaça MV, Sartim AG, et al. (2018) Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex. Mol Neurobiol 56: 1070–1081. |
[38] |
Lee JLC, Bertoglio LJ, Guimarães FS, et al. (2017) Cannabidiol regulation of emotion and emotional memory processing: Relevance for treating anxiety-related and substance abuse disorders. Br J Pharmacol 174: 3242–3256. doi: 10.1111/bph.13724
![]() |
[39] |
Cooper RE, Williams E, Seegobin S, et al. (2017) Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. Eur Neuropsychopharmacol 27: 795–808. doi: 10.1016/j.euroneuro.2017.05.005
![]() |
[40] |
Babson KA, Sottile J, Morabito D (2017) Cannabis, cannabinoids, and sleep: A review of the literature. Curr Psychiatry Rep 19: 23. doi: 10.1007/s11920-017-0775-9
![]() |
[41] | Parker W, Hornik CD, Bilbo S, et al. (2017) The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism. J Int Med Res 45: 407–438. |
[42] |
Hill AJ, Williams CM, Whalley BJ, et al. (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133: 79–97. doi: 10.1016/j.pharmthera.2011.09.002
![]() |
[43] | Solimini R, Rotolo MC, Pichini S, et al. (2017) Neurological disorders in medical use of cannabis: An update. CNS Neurol Disord Drug Targets 16: 527–533. |
[44] |
Urdaneta KE, Castillo MA, Montiel N, et al. (2018) Autism spectrum disorders: Potential neuro-psychopharmacotherapeutic plant-based drugs. Assay Drug Dev Technol 16: 433–444. doi: 10.1089/adt.2018.848
![]() |
1. | Jordi Ripoll, Jordi Font, Numerical approach to an age-structured Lotka-Volterra model, 2023, 20, 1551-0018, 15603, 10.3934/mbe.2023696 | |
2. | Desmond Z. Lai, Julia R. Gog, Waning immunity can drive repeated waves of infections, 2024, 21, 1551-0018, 1979, 10.3934/mbe.2024088 | |
3. | Dongxue Yan, Yongxian Jin, Hui Cao, Yu Cao, Stability and Hopf Bifurcation for a delayed hand–foot–mouth disease model with continuous age-structure in the exposed class, 2025, 84, 14681218, 104310, 10.1016/j.nonrwa.2024.104310 |